Skip to content

Effect of rectal Progesterone on Latent Phase Prolongation in Patients with Preterm Premature Rupture of Membranes

Effect of rectal Progesterone on Latent Phase Prolongation in Patients with Preterm Premature Rupture of Membranes on Neonatal and Maternal outcomes , A clinical trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200610047716N1
Enrollment
110
Registered
2020-08-18
Start date
2019-12-22
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PPROM.

Interventions

Intervention 1: Intervention group: Recipients of rectal progesterone suppository 400 mg ( Abu Reihan Company production), once a day. Intervention 2: Control group: No therapeutic intervention.

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women 18-45 years Fetus age between 26-34 weeks based on first trimester of pregnancy ultrasound PPROM diagnosis based on observation of leakage during speculum examination, nitrazine positive test that these pregnant mothers PPROM without labor pain

Exclusion criteria

Exclusion criteria: Fetus chromosomal abnormalities Abnormal biophysical profiles less than 4 Intrauterine growth restriction and weight less than ten percent according to the Alexander Growth Standard Maternal fever greater than 38 ° C Bleeding after week 24 Chorioamnionitis based on maternal criteria Type 1 diabetes Preeclampsia includes high blood pressure and proteinuria after 20 weeks of pregnancy Cervical discharge and severe obstetric medical diseases Taking corticosteroids or systemic steroids Receive antibiotics one week before hospital admission and antibiotic sensitivity

Design outcomes

Primary

MeasureTime frame
Increased latent phase of labor. Timepoint: From the beginning of the latent phase to the end of the latent phase. Method of measurement: Measurement of latent phase duration based on clinical examination.;Neonatal Apgar score. Timepoint: Apgar score of the first and fifth minutes after birth. Method of measurement: Based on Apgar scoring criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Behnaz Gonabadi

Gorgan University of Medical Sciences

gonabadibehnaz@gmail.com+98 17 3220 2565

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026